BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7781707)

  • 1. Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptors.
    Schoeffter P; Pérez J; Langenegger D; Schüpbach E; Bobirnac I; Lübbert H; Bruns C; Hoyer D
    Eur J Pharmacol; 1995 Mar; 289(1):163-73. PubMed ID: 7781707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors.
    Hoyer D; Pérez J; Schoeffter P; Langenegger D; Schüpbach E; Kaupmann K; Lübbert H; Bruns C; Reubi JC
    Eur J Pharmacol; 1995 Mar; 289(1):151-61. PubMed ID: 7781706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
    Siehler S; Zupanc GK; Seuwen K; Hoyer D
    Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and pharmacological characterization of somatostatin sst2 sites in the rat cerebellum.
    Piwko C; Thoss VS; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):607-13. PubMed ID: 9053731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization.
    Thoss VS; Piwko C; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):648-60. PubMed ID: 8738298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
    Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
    Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
    Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterisation of human cerebral cortex somatostatin SRIF1 and SRIF2 receptors.
    Piwko C; Thoss VS; Schüpbach E; Kummer J; Langenegger D; Probst A; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):161-7. PubMed ID: 9050007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.
    Fehlmann D; Langenegger D; Schuepbach E; Siehler S; Feuerbach D; Hoyer D
    J Physiol Paris; 2000; 94(3-4):265-81. PubMed ID: 11088004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and pharmacological characterization of somatostatin receptors in rat lung.
    Schloos J; Raulf F; Hoyer D; Bruns C
    Br J Pharmacol; 1997 Jul; 121(5):963-71. PubMed ID: 9222554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):522-32. PubMed ID: 10598791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary.
    Thoss VS; Piwko C; Probst A; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):168-76. PubMed ID: 9050008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
    Siehler S; Seuwen K; Hoyer D
    Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.
    Feuerbach D; Fehlmann D; Nunn C; Siehler S; Langenegger D; Bouhelal R; Seuwen K; Hoyer D
    Neuropharmacology; 2000 Jun; 39(8):1451-62. PubMed ID: 10818261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization and pharmacological characterization of somatostatin recognition sites in the human cerebellum.
    Piwko C; Thoss VS; Probst A; Hoyer D
    Neuropharmacology; 1996 Jun; 35(6):713-23. PubMed ID: 8887980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
    Hadcock JR; Strnad J; Eppler CM
    Mol Pharmacol; 1994 Mar; 45(3):410-6. PubMed ID: 8145728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtypes of somatostatin receptors are expressed in the anterior pituitary cell line GH3.
    Raynor K; Reisine T
    J Pharmacol Exp Ther; 1993 Jan; 264(1):110-6. PubMed ID: 8093718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa.
    McKeen ES; Feniuk W; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):402-11. PubMed ID: 8532068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.